News

RITA Shows Good Patency After 10 Years


 

SAN DIEGO – Although the right internal thoracic artery is biologically identical to the left internal thoracic artery, it is rarely used in coronary artery bypass grafting.

In a study comparing the use of different graft sources for CABG, Dr. James Tatoulis and his colleagues found that the right internal thoracic artery (RITA) showed equivalent results to using the left internal thoracic artery (LITA).

Dr. Tatoulis of the Royal Melbourne Hospital and his colleagues evaluated consecutive RITA graft angiograms performed from 1986 to 2008. Patency was examined over time by coronary territory and by whether the RITA was in situ or free, and was compared with other coronary conduits.

A total of 5,766 patients had a RITA graft, usually as part of bilateral internal thoracic artery CABG. The operative mortality was 1.1%, and the rate of deep sternal infection was 1.5%. Of the nearly 7,800 coronary conduits studied, 991 RITA conduits were examined at a mean of 100 months postoperatively.

The overall 10-year RITA patency was 90%. RITA graft patency to the left anterior descending artery (n = 149) was 95% at 10 years and 90% at 15 years. Ten-year RITA patency to the circumflex marginal artery was 91% (n = 436), 85% (n = 199) to the right coronary artery (RCA), and 86% (n = 207) to the posterior descending artery (PDA). Ten-year patencies of RITA and LITA to the left anterior descending artery were identical.

In situ RITA (n = 451) and free RITA (n = 540) had similar 10-year patencies, 89% vs. 91% respectively.

RITA patency was found to be significantly better than radial artery and saphenous vein grafts for the circumflex marginal artery, the RCA, and the PDA. The 10-year survival of patients with RITA and LITA for triple-vessel coronary disease was identical at 89%.

Dr. Tatoulis and his colleagues reported that they had no relevant disclosures.

Recommended Reading

Stroke History Did Not Alter Dabigatran's Safety, Efficacy
MDedge Cardiology
Guidelines Revised for Poststroke Prevention
MDedge Cardiology
Novel Antiplatelet Agent Passes Safety Hurdle
MDedge Cardiology
Job-Stressed Women Face Higher MI Risk
MDedge Cardiology
CV, Arthritis Markers Predict Cardiac Events
MDedge Cardiology
Ticagrelor for ACS Cuts 1-Year Health Costs
MDedge Cardiology
Stenting Was Good Fallback In Large-Vessel Strokes
MDedge Cardiology
Thrombectomy for Acute MI Not Yet Embraced
MDedge Cardiology
Program Genotypes All Cardiac Cath Patients
MDedge Cardiology
High-Dose Clopidogrel Ineffective in Nonresponsive Patients
MDedge Cardiology